Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer

Genetics and Molecular Biology

Volumn 34, Issue 4, 2011, Pages 546-552

  Pérez Morales, Rebeca ^a,c   Méndez Ramírez, Ignacio ^b   Castro Hernández, Clementina ^a   Martínez Ramírez, Ollin C ^a   Gonsebatt, María Eugenia ^a   Rubio, Julieta ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b IIMAS UNAM   (Mexico)

^c UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

Additive model; Genetic polymorphism; Lung cancer; Mexicans; Molecular epidemiology

Indexed keywords

ADULT; AHR GENE; ALLELE; ARTICLE; CANCER RISK; CCND1 GENE; CYP1A1 GENE; EPHX1 GENE; ERCC2 GENE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; LINKAGE ANALYSIS; LUNG CANCER; MALE; MEXICO; MGMT GENE; MUTATOR GENE; NORMAL HUMAN; POPULATION GENETIC STRUCTURE; RISK ASSESSMENT; TP53 GENE; XRCC1 GENE;

EID: 82355168979     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572011005000053     Document Type: Article

References (46)

1. Abdel-Rahman S and El-Zein R (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the geno-toxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 159:63-71.
2. Abdel-Rahman S, El-Zein R, Anwar W and Au W (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 107:229-233.
3. Cascorbi I, Brockmöller J and Roots I (1996)A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56:4965-4969.
4. 6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK. Pharmacogenet Genomics 15:571-578.
5. Dong L, Potter J, White E, Ulrich C, Cardon L and Peters U (2008) Genetic susceptibility to cancer: The role of polymorphism in candidate genes. JAMA 299:2423-2434.
6. Fletcher O and Houlston R (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353-361.
7. Gallegos-Arreola M, Figuera-Villanueva L, Troyo-Sanroman R, Morgan-Villela G, Puebla-Pérez AM, Flores Márquez MR and Zúñiga-González GM (2008) CYP1A1*2B and *4 polymorphism are associated with lung cancer susceptibility in Mexican patients. Int J Biol Markers 23:1-7.
8. Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lis-sowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, et al. (2007) Development of lung cancer before the age of 50: The role of xenobiotic metabolizing genes. Carcinogenesis 28:1287-1293.
9. Harries L, Stubbins M, Forman D, Howard G and Wolf R (1997) Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644.
10. Hassett C, Aicher L, Sidhu J and Omiecinski C (1994) Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421-428.
11. Hayashi S, Watanabe J, Nakachi Kand Kawajiri K (1991) Genetic linkage of lung cancer-associated MspI polymorphism with amino acid replacement in the heme binding region of the human cytochrome P450IA1. J Biochem 110:407-411.
12. Hosgood III H, Menashe I, Shen M, Yeager M, Yuenger J, Rajaraman P, He X, Chatterjee N, Caporasso N, Zhu Y, et al. (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29:1938-1943.
13. Hung R, Boffeta P, Brockmöller J, Haugen A, Butkiewicz D, Cascorbi I, Clapper M, Garte S, Hirvonen A, Anttila S, et al. (2003) CYP1A1 and GSTM1 genetic polymorphism and lung cancer risk in Caucasian non-smokers: A pooled analysis. Carcinogenesis 24:875-882.
14. Hung R, Baragatti M, Thomas D, McKay J, Szeszenia-Da-browska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, et al. (2007) Inherited predisposition of lung cancer: A hierarchical modeling approach to DNA repair and cell cycle control pathways. Cancer Epidemiol Biomarkers Prev 16:2736-2744.
15. Irarrázabal C, Rojas C, Aracena R, Márquez C and Gil L (2003) Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett 144:69-76.
16. Kawajiri K (1999) Metabolic polymorphism and susceptibility to cancer. Chapter 15 CYP1A1. IARC Sci Publ 148:159-172.
17. Ketelslegers H, Gottschalk R, Godschalk R, Knaapen AD, Scho-oten F, Vlietnick F, Kleinjans J and Van Delft J (2006) Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphism in smokers. Cancer Epidemiol Biomarkers Prev 15:624-629.
18. Kiyohara C and Yoshimasu K (2007) Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis. Int J Med Sci 4:59-71.
19. Kiyohara C, Yoshimasu K, Takayama K and Nakanishi Y (2007) Lung cancer susceptibility: Are we on our way to identifying a high-risk group? Future Oncol 3:617-627.
20. Kvitko K, Nunes J, Weimer T, Salzano F and Hutz M (2000) Cytochrome P4501A1 polymorphisminSouth American Indians. Hum Biol 72:1039-1043.
21. Lee K, Kang D, Clapper M, Ingelman-Sundberg M, Ono-Kihara M, Kiyohara C, Min S, Lan Q, Le Marchand L, Lin P, et al. (2008) CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 17:1120-1126.
22. Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu M, Boddi V and Dolara P (2004) Benzo(a)pyrene diolepo-xide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1 and mEH. Cancer Epidemiol Biomarkers Prev 13:1342-1348.
23. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK and Bell DA (2000) XPD polymorphism: Effects on DNA repair proficiency. Carcinogenesis 21:551-555.
24. Mohr L, Rodgers K and Silvestri G (2003) Glutathione S-trans-ferase M1 polymorphism and the risk of lung cancer. Anti-cancer Res 23:2111-2124.
25. Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T, Kishibuti M, Fujita J, Ogawa A and Taniguchi M (1997) CYP1A1, CYP2E1 and GSTM1 polymorphism are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 71:192-195.
26. Nebert D and Dalton T (2006) The role of cytochrome P450 enzymes in endogenous signaling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947-960.
27. Pérez-Morales R, Castro-Hernández C, Gonsebatt M and Rubio J (2008) Polymorphism of CYP1A1*2C, GSTM1*0, and GSTT1*0 in a Mexican Mestizo population: A similitude analysis. Hum Biol 80:457-465.
28. Pharoah P, Antoniou A, Bobrow M, Zimmern R, Easton D and Ponder B (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36.
29. Proctor R (2001) Tobacco and the global lung cancer epidemic. Nat Rev Cancer 1:82-86.
30. Quinoñes L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, Lee K, Acevedo C, Martínez L, Aguilera A, et al. (2001) CYP1A1, CYP2E1 and GSTM1 genetic polimorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35-44.
31. Ruíz-Godoy L, Rizo P, Sánchez F, Osornio-Vargas A, García-Cuellar C and Meneses A. Mortality due to lung in Mexico. Lung Cancer 58:184-190.
32. Salam M, Lin P, Avol E, Gauderman J and Gilliland F (2007) Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma. Thorax 62:1050-1057.
33. Sambrook J, Fritsch EF and Maniatis T (1987) Molecular Cloning. A Laboratory Manual. 2nd edition. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
34. Shah P, Singh A, Singh M, Mathur N, Pant M, Mishra B and Parmar D (2008) Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 639:1-10.
35. Shaw G, Falk R, Frame J, Weiffenbach B, Nesbitt J, Pass H, Caporaso N, Moir D and Tucker M (1998) Genetic polymorphism of CYPD6 and lung cancer risk. Cancer Epidemiol Biomarker Prev 7:215-219.
36. Smith C and Harrison D (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630-633.
37. Sobti R, Kaur P, Kaur S, Janmeja A, Jindal S, Kishan J and Raimondi S(2008) Combined effect ofGSTM1, GSTT1, and GSTP1 polymorphism on histological subtypes of lung cancer. Biomarkers 13:282-295.
38. Taioli E, Ford J, Trachman J, Li Y, Demopoulos R and Garte S (1998) Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19:813-817.
39. Vineis P, Manuguerra M, Kavvoura F, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis J, et al. (2009) A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24-36.
40. Voho A, Metsola K, Anttila S, Impivaara O, Järvisalo J, Vainio H, Husgafvel-Pursiainen K and Hirvonen A (2006) EPHX1 gene polymorphism and individual susceptibility to lung cancer. Cancer Lett 237:102-108.
41. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamamoto T, Kakei Y, Kakinuma H, Sato K, Nakamura A, Ogawa O, et al. (2002) Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23:257-264.
42. Xie Y and Minna J (2008) Predicting the future for people with lung cancer. Nat Med 14:812-813.
43. Yoon K, Kim J, Gil H, Hwang H, Hwangbo B and Lee J (2008) CYP1B1, CYP1A1, MPO, and GSTP1 polymorphism and lung cancer in never-smoking Korean women. Lung Cancer 60:40-46.
44. Zhan P, Wang J, Zhang Y, Qiu L, Zhao S, Qian Q, Wei S, Yu L and Song Y (2010) CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer 69:19-25.
45. Zhou W, Liu G, Thurston S, Xu L, Miller D, Wain J, Lynch T, Su L and Christiani DC (2002) Genetic polymorphism in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarker Prev 11:15-21.
46. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F and Haugen A (2006) Polymorphism of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27:560-567.